https://www.selleckchem.com/products/Rolipram.html
The purpose of this study was to examine the physiological mechanisms of persistent dyspnoea in COVID-19 survivors. Non-critical patients (n = 186) with varying degrees of COVID-19 severity reported persistent symptoms using a standardized questionnaire and underwent pulmonary function and 6-minute walk testing between 30 and 90 days following the onset of acute COVID-19 symptoms. Patients were divided into those with (n = 7 and without (n = 116) persistent dyspnoea. Patients with persistent dyspnoea had significantly lower FVC (p =